REJURAN I
Revitalise Your Eyes with Rejuran®I: Under Eye Wrinkle Treatment in Perth
Skin aging manifests through characteristics like wrinkles, decreased elasticity, laxity, and a rough texture, typically beginning in the mid to late 20s. This process involves structural and functional alterations in extracellular matrix elements like collagens and elastin, leading to epidermal and dermal thinning. Exposure to environmental stressors over time exacerbates skin dehydration, roughness, and hyperpigmentation, resulting in a lacklustre, fatigued appearance.
REJURAN®I offers an innovative solution targeting concerns such as dark circles, wrinkles, and puffiness. It prompts skin regeneration and repairs while minimizing inflammation. Derived from wild salmon polynucleotide DNA fragments of specific size, this treatment comprises a clear, colourless viscous solution that activates the skin's inherent repair mechanisms, restoring the dermal and epidermal biology. By delivering bio-compatible polynucleotides directly to the delicate skin around the eyes.
REJURAN®I enhances collagen production, smoothens wrinkles, and revitalises the under-eye area, promoting overall skin health naturally.
More Information
Treatment Areas
- Under eye area – puffiness, bags, dark circles, wrinkles
Benefits
An innovative treatment to address dark eye circles, wrinkles, and eye bags.
- Reduces inflammation
- Improves micro-circulation
- Increases skin elasticity
- Improves skin tone and texture
- Minimal downtime
Results
Results generally are visible after 4 weeks
- Initial treatment plan is 3 sessions at 3-week intervals
- Maintenance treatment at 6 monthly intervals
Who is suitable for REJURAN®I
- Dark under eye circles
- Puffiness or under-eye bags
More Common Side Effects
- Minor redness and visible bumps, these usually subside within 24-48 hours
Are there any risks involved with REJURAN®I
The REJURAN®I injections available in Australia have been extensively researched and have been proven to be safe for most. As with any medication, potential complications and side effects can occur but are uncommon.
Frequently Asked Questions
Who is not suitable for treatment?
- Pregnant and breastfeeding women should avoid as there is not sufficient clinical data to support safe treatment in this group.